September 29, 2021
521
76
29
20.15%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
10:39Now PlayingPharma companies argue that lower drug prices would mean fewer breakthrough drugs. Is that true?
This week on 51/49, James examines whether it’s true that even though 90% of Americans are in favor of regulating big pharma, the lowering of prescription drug prices in the United States would disincentivize innovation, and therefore result in fewer and fewer life saving drugs in the long run, and why so many members of Congress, both Republican and Democrat, are so keen to block the provision to allow Medicare to negotiate with pharmaceutical companies for lower drug prices.
51/49 with James Li - Commentary on business, politics, and the other things (from an independent perspective)
Follow James on Twitter
Subreddit link
-----
Fair Use Notice: This video may contain copyrighted material; the use of which has not been specifically authorized by the copyright owner. We are making such material available for the purposes of criticism, comment, review and news reporting which constitute the fair use of any such copyrighted material as provided for in section 107 of the US Copyright Law. Not withstanding the provisions of sections 106 and 106A, the fair use of a copyrighted work for purposes such as criticism, comment, review and news reporting is not an infringement of copyright.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.